Toni K. Choueiri

Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects

C. Paweletz, M. Ficial, B. Piel, 2024, Molecular cancer.

Immune-restoring CAR-T cells display antitumor activity and reverse immunosuppressive TME in a humanized ccRCC mouse model

D. Braun, Aedin C. Culhane, Q. Zhu, 2024, iScience.

Response to single agent PD-1 inhibitor after progression on previous PD-1/PD-L1 inhibitors: a case series

T. Choueiri, F. Hodi, P. Ott, 2017, Journal of Immunotherapy for Cancer.

Safety and Efficacy Outcomes of Early Cessation of Anti-PD1 Therapy in Patients 80 Years or Older: A Retrospective Cohort Study.

M. Filetti, D. Mallardo, S. Buti, 2024, Cancer letters.

A framework for target discovery in rare cancers

John G Doench, S. Viswanathan, Jiao Li, 2024, bioRxiv.